Patients with higher medication complexity, such as patients with cancer, are particularly vulnerable to medication safety events (MSEs). This qualitative study with patients with breast, prostate, lung, and colorectal cancer identified several barriers to the use of technology for MSE self-reporting, such as limited access to technology and low confidence in using technology.